Seoul, South Korea

Byung Seok Moon

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Bio Imaging Korea Co., Ltd., Snu Rdb Foundation. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung Seok Moon. Retrieved from https://idiyas.com/inventor/byung-seok-moon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gyeonggi-Do, KR (2014)
  • Seoul, KR (2014 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Byung Seok Moon: Innovator in Medical Imaging Technologies

Introduction

Byung Seok Moon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical imaging, particularly in the development of innovative compounds for diagnostic and therapeutic applications. With a total of three patents to his name, Moon's work is at the forefront of advancing medical technology.

Latest Patents

One of his latest patents is titled "Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof." This invention relates to the preparation of tricarbonyl technetium-99m or rhenium-188 labeled cyclic RGD derivatives, which are used in the diagnosis and treatment of angiogenesis-related diseases. The derivatives exhibit a high subnanomolar affinity to integrin αvβ3, which is activated in tumor-induced angiogenesis, allowing for targeted action on cancer cells while minimizing uptake in the liver and intestines.

Another notable patent is the "Method for preparation of fluorine-18-labeled flumazenil using diaryliodonium salt precursor." This patent discloses a synthesis method for [F]flumazenil, which is useful in imaging epileptic lesions through positron emission tomography (PET). The method involves reacting a diaryliodonium salt precursor with fluorine-18 in the presence of kryptofix/potassium carbonate and TEMPO, achieving high yields.

Career Highlights

Byung Seok Moon has worked with several organizations, including Bio Imaging Korea Co., Ltd. and Snur & Db Foundation. His experience in these companies has allowed him to collaborate on various projects aimed at enhancing medical imaging technologies.

Collaborations

Some of his notable coworkers include Byung Chul Lee and Sang Eun Kim. Their collaborative efforts have contributed to the successful development of innovative medical imaging solutions.

Conclusion

Byung Seok Moon's contributions to the field of medical imaging through his patents and collaborations highlight his role as a key innovator. His work continues to impact the diagnosis and treatment of diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…